Gainers
- Paratek Pharmaceuticals PRTK shares moved upwards by 9.7% to $5.65 during Monday's after-market session. Today's trading volume for this security ended up closing at 80.6K shares, which is 17.4 percent of its average volume over the last 100 days. The company's market cap stands at $275.6 million.
- Scopus BioPharma SCPS shares increased by 5.73% to $4.24. The market value of their outstanding shares is at $76.7 million.
- Altimmune ALT stock moved upwards by 5.33% to $16.0. At the close, Altimmune's trading volume reached 99.8K shares. This is 6.09% of its average volume over the last 100 days. The market value of their outstanding shares is at $635.2 million.
- SeaSpine Holdings SPNE shares rose 4.59% to $15.95. The company's market cap stands at $580.5 million.
- Aytu BioPharma AYTU stock increased by 4.48% to $3.26. Aytu BioPharma's trading volume hit 99.0K shares by close, accounting for 19.24% of its average volume over the last 100 days. The market value of their outstanding shares is at $89.8 million. The company's, Q4 earnings came out today.
- NanoVibronix NAOV shares increased by 4.06% to $2.05. The market value of their outstanding shares is at $49.4 million.
Losers
- Concord Medical Services CCM stock fell 14.93% to $2.68 during Monday's after-market session. The market value of their outstanding shares is at $116.3 million.
- ZIOPHARM Oncology ZIOP shares decreased by 9.91% to $1.91. Today's trading volume for this security ended up closing at 70.4K shares, which is 2.19 percent of its average volume over the last 100 days. The company's market cap stands at $411.7 million.
- Brookdale Senior Living BKD stock decreased by 7.08% to $5.71. Trading volume for this security closed at 222.5K, accounting for 13.93% of its average full-day volume over the last 100 days. The company's market cap stands at $1.0 billion.
- Corvus Pharmaceuticals CRVS shares decreased by 6.13% to $7.2. Trading volume for this security closed at 93.3K, accounting for 1.29% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $305.4 million.
- Verastem VSTM stock decreased by 4.99% to $3.05. The market value of their outstanding shares is at $551.3 million.
- Entasis Therapeutics Hldg ETTX stock declined by 3.81% to $3.29. The company's market cap stands at $155.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in